NASDAQ Volatile Stocks: Dipexium Pharmaceuticals (NASDAQ:DPRX), Innodata (NASDAQ:INOD), Huttig Building Products (NASDAQ:HBP), MGC Diagnostics (NASDAQ:MGCD)

Zacks started coverage on shares of Dipexium Pharmaceuticals Inc (NASDAQ:DPRX). The firm issued a hold rating on the stock. Dipexium Pharmaceuticals Inc (NASDAQ:DPRX) stock performance was 4.53% in last session and finished the day at $9.70. Traded volume was 14,020.00million shares in the last session and the average volume of the stock remained 114.51K shares. Dipexium Pharmaceuticals Inc (NASDAQ:DPRX) insider ownership is 47.40%.

INNODATA INC. (NASDAQ: INOD) announced today that Stephen Talnose has joined Innodata Inc (NASDAQ:INOD)`s Synodex subsidiary where he will lead sales and account management. Innodata Inc (NASDAQ:INOD) rose 8.76 percent to $2.98 Monday on volume of 18,467.00million shares. The intra-day range of the stock was $2.70 to $3.00. Innodata Inc (NASDAQ:INOD) has a market capitalization of $74.65million.

In 1994, the DEQ named Huttig Building Products Inc (NASDAQ:HBP) the liable party for cleaning hazardous chemicals spilled on the land during decades of window sash production. This year, the agency proposed a controversial remediation order for the property. Due to “significant local interest” in the site, the DEQ extended the public comment period through Monday. Huttig Building Products Inc (NASDAQ:HBP)’s stock on Apr 21, 2014 reported a increase of 3.75% to the closing price of $4.70. Its fifty two weeks range is $2.00 -$5.30. The total market capitalization recorded $115.51million. The overall volume in the last trading session was 13,840.00million shares. In its share capital, HBP has 24.57million outstanding shares.

InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading national provider of infusion pumps and related services for the healthcare industry in the United States, today announced that the InfuSystem Board of Directors has nominated Gregg O. Lehman, Ph.D., 66, Chief Executive Officer and President of MGC Diagnostics Corp (NASDAQ:MGCD), a global medical technology company, to stand for election to the Board at the 2014 Annual Meeting of Shareholders. On Monday, shares of MGC Diagnostics Corp (NASDAQ:MGCD) advanced 7.91% to close the day at $11.19. Company return on investment (ROI) is 7.30% and its monthly performance is recorded as -9.79%. MGC Diagnostics Corp (NASDAQ:MGCD) quarterly revenue growth is 6.58%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone